<- Go home

Added to YB: 2021-07-12

Pitch date: 2021-07-12

ABCM:US [bullish]

Abcam Limited

+28.29%

current return

Author Info

No bio for this author

Company Info

Abcam Limited, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery.

Market Cap

$4.4B

Pitch Price

$18.70

Price Target

N/A

Dividend

N/A

EV/EBITDA

38.59

P/E

1.8K

EV/Sales

11.90

Sector

Biotechnology

Category

N/A

Show full summary:
Abcam PLC Sponsored ADR ABCM:US

A summary for this pitch has not been created yet.

Read full article (0 min)